Article
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma
2025-04-16
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> : Immunotherapy is efficacious in hepatocellular carcinoma (HCC), but the benefits are limited to a minority of patients. Most HCC patients show resistance to immune checkpoint blockade (ICB). Agonists of the stimulator of interferon genes (STING), potent immune stimulators, showed limited effectiveness. Using preclinical models, we studied the mechanisms of r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6fa588bf-e9c1-5d6b-9f2b-d1bcb4a9c148
- DOI
- 10.21203/rs.3.rs-6355345/v1
